Katherine Stueland
Chief Executive Officer at GeneDx Holdings Corp.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GeneDx Holdings Corp. June 18, 202675.7%
-
GeneDx Holdings Corp. June 14, 202377.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | GeneDx Holdings Corp. | Option exercise | +18,750 | — | — |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −1,648 | $94.26 | $155,340 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −148 | $95.41 | $14,121 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −1,525 | $96.90 | $147,773 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −4,141 | $98.27 | $406,936 |
| Sep 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,039 | $99.00 | $300,861 |
| Sep 9, 2026 | GeneDx Holdings Corp. | Option exercise | +6,547 | — | — |
| Sep 9, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,692 | $84.22 | $310,940 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Option exercise | +18,750 | — | — |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −2,140 | $59.75 | $127,865 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −5,932 | $60.83 | $360,844 |
| Jun 16, 2026 | GeneDx Holdings Corp. | Open-market sale | −2,429 | $61.50 | $149,384 |
| Jun 9, 2026 | GeneDx Holdings Corp. | Option exercise | +6,546 | — | — |
| Jun 9, 2026 | GeneDx Holdings Corp. | Open-market sale | −3,639 | $53.77 | $195,669 |
| Apr 29, 2026 | GeneDx Holdings Corp. | Option exercise | +3,874 | — | — |
Questions about Katherine Stueland
What boards is Katherine Stueland on?
Katherine Stueland sits on the board of GeneDx Holdings Corp.
What company is Katherine Stueland the CEO of?
Katherine Stueland is Chief Executive Officer of GeneDx Holdings Corp.
How long has Katherine Stueland served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.